Form 4: Cullinan Therapeutics Chief Legal Officer Sells Shares to Cover Tax Obligations

Jacquelyn L. Sumer, Chief Legal Officer of Cullinan Therapeutics, Inc., sold 3,756 shares of common stock on February 25, 2025, to cover personal income tax obligations upon vesting of restricted stock units.

Summary

• On February 25, 2025, Jacquelyn L. Sumer, the Chief Legal Officer of Cullinan Therapeutics, Inc. (CGEM), sold 3,756 shares of the company's common stock.
• The sale was executed at a price of $8.53 per share.
• The transaction was conducted to cover personal income tax obligations arising from the vesting of restricted stock units.
• Following the transaction, Sumer directly owns 136,895 shares of Cullinan Therapeutics.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily indicate a positive or negative outlook for the company.

Industry Context

Form 4 filings are a routine part of the US financial market, providing transparency into the transactions of company insiders. This filing indicates that a company insider sold shares, which is a common occurrence for covering tax obligations related to stock-based compensation.

Stakeholder Impact

• The sale of shares by an insider could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.

Key Dates